Global Retirement Partners’s Centessa Pharmaceuticals CNTA Stock Holding History

Global Retirement Partners’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$5K	Sell	200 -150	-43%	-$3.8K	﹤0.01%	3439
2025 Q3	$8.49K	Hold	350	–	–	﹤0.01%	2761
2025 Q2	$4.6K	Buy	+350	New	+$4.43K	﹤0.01%	2943
2024 Q4	$11.7K	Hold	700	–	–	﹤0.01%	2338
2024 Q3	$11.2K	Hold	700	–	–	﹤0.01%	2249
2024 Q2	$6.32K	Hold	700	–	–	﹤0.01%	2507
2024 Q1	$7.91K	Hold	700	–	–	﹤0.01%	2217
2023 Q4	$5.11K	Hold	700	–	–	﹤0.01%	2315
2023 Q3	$4.12K	Hold	700	–	–	﹤0.01%	2259
2023 Q2	$4.33K	Hold	700	–	–	﹤0.01%	2257
2023 Q1	$3.04K	Hold	700	–	–	﹤0.01%	2355
2022 Q4	$2.17K	Buy	700 +350	+100%	+$1.3K	﹤0.01%	2331
2022 Q3	$1K	Hold	350	–	–	﹤0.01%	2409
2022 Q2	$2K	Hold	350	–	–	﹤0.01%	2170
2022 Q1	$2K	Buy	+350	New	+$3.19K	﹤0.01%	2151

Other funds holding CNTA

MVM

Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

IVLAV

Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Global Retirement Partners's CNTA Position: Q4 2025 in Review

Global Retirement Partners reduced its Centessa Pharmaceuticals (CNTA) stake by 43% in Q4 2025, selling an estimated $3.8K and leaving 200 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #3439.

Global Retirement Partners first reported a position in CNTA in Q1 2022 and has held it in 15 quarters since. The position peaked at $11.7K in Q4 2024. 146 funds tracked by Wall St. Rank hold CNTA as of Q4 2025.

Global Retirement Partners held 200 shares of Centessa Pharmaceuticals worth $5K as of Q4 2025.
Global Retirement Partners sold 150 Centessa Pharmaceuticals shares in Q4 2025, an estimated $3.8K.
Centessa Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3439 holding.
Global Retirement Partners first reported a position in Centessa Pharmaceuticals in Q1 2022 and has held it in 15 quarters since.
Global Retirement Partners's Centessa Pharmaceuticals position peaked at $11.7K in Q4 2024.
146 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.